Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial.
CD133靶向CAR T细胞治疗晚期肝细胞癌的疗效和生物标志物分析：一项单臂、开放标签的II期试验
期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2020.1846926
Dai Hanren, Tong Chuan, Shi Daiwei, Chen Meixia, Guo Yelei, Chen Deyun, Han Xiao, Wang Hua, Wang Yao, Shen Pingping
